Evaluation of PK and Safety of D-0120 and Allopurinol

Completed · Early Phase 1

Conditions studied: Healthy

In brief

Evaluation of safety and PK interaction between D-0120 and Alopurinol in healthy adult subjects

Key facts

Study ID

NCT05360628

Run by

InventisBio Co., Ltd

People needed

20

Starts

2021-11-01

Expected to finish

2022-07-23

Last updated by the study team

2023-03-01

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subjects between the ages of 18-55
• Required evaluation by Investigator for screening and enrollment
• Agreement and compliance with the study and follow-up procedures

You may not qualify if…

• Significant medical history or current comorbidly determined by the Investigator.
• Pregnant or nursing women

Where it is running

• Spaulding Clinical — West Bend, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.